Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients

Abstract Background Ovarian cancer (OC) is one of the most malignant gynecological tumors, associated with excess death rate (50-60%) in ovarian cancer patients. Particularly, among newly occurred ovarian cancer patients, 70% of clinical cases are diagnosed at the advanced stage, which definitely de...

Full description

Saved in:
Bibliographic Details
Main Authors: Lei Zhang (Author), Min Luo (Author), Hongying Yang (Author), Shaoyan Zhu (Author), Xianliang Cheng (Author), Chen Qing (Author)
Format: Book
Published: BMC, 2019-02-01T00:00:00Z.
Subjects:
Online Access:Connect to this object online.
Tags: Add Tag
No Tags, Be the first to tag this record!

MARC

LEADER 00000 am a22000003u 4500
001 doaj_b18d2e2729b64eb0be39d117e69b48df
042 |a dc 
100 1 0 |a Lei Zhang  |e author 
700 1 0 |a Min Luo  |e author 
700 1 0 |a Hongying Yang  |e author 
700 1 0 |a Shaoyan Zhu  |e author 
700 1 0 |a Xianliang Cheng  |e author 
700 1 0 |a Chen Qing  |e author 
245 0 0 |a Next-generation sequencing-based genomic profiling analysis reveals novel mutations for clinical diagnosis in Chinese primary epithelial ovarian cancer patients 
260 |b BMC,   |c 2019-02-01T00:00:00Z. 
500 |a 10.1186/s13048-019-0494-4 
500 |a 1757-2215 
520 |a Abstract Background Ovarian cancer (OC) is one of the most malignant gynecological tumors, associated with excess death rate (50-60%) in ovarian cancer patients. Particularly, among newly occurred ovarian cancer patients, 70% of clinical cases are diagnosed at the advanced stage, which definitely delay the timely treatment and lead to high mortality rate within 5 years post diagnosis. Therefore, identification of sensitive gene markers, as well as development of reliable genetic diagnosis, are important for the early detection and precise therapy for OC patients. This study aims to identify novel genetic mutations and develop a feasible clinical approach for early OC diagnosis. Methods The OC tissue-derived DNA sample was acquired from 31 OC patients, and the somatic gene mutations will be identified after comparison with normal samples, using Genome-wide analysis and next-generation sequencing. Results A total of 463 somatic mutations, which were considered as potential pathogenic sites, were assigned to 473 genes. Among them, 15 genes (TP53, TTN, MUC16, OR4N2, BRCA1, CAD, CCDC129, INSR, NAV3, NELL2, NRAS, OBSCN, PGLYRP4, RBM15B and TRPC7) were mutated on at least two sites. These genes were mapped to RNA sequencing (RNAseq) data, and a total of 117 genes had an absolute fold- change ≥ 2 and p ≤ 0.01. Five genes were mutated in at least two OC patients. Gene ontology (GO) classification indicated that a majority of genes participated in biological processes. Kyoto Enrichment of Genes and Genomes (KEGG) enrichment pathway analysis revealed that the genes were mainly involved in the regulation of metabolic signaling pathways. Conclusions Taken together, this study identified several novel genetic alterations pathway for early clinical diagnosis and provided abundant information for understanding molecular mechanisms of the OC occurrence and development. 
546 |a EN 
690 |a Epithelial ovarian cancer 
690 |a Oncogenesis 
690 |a Expression profiling 
690 |a Pathway analysis 
690 |a Gynecology and obstetrics 
690 |a RG1-991 
655 7 |a article  |2 local 
786 0 |n Journal of Ovarian Research, Vol 12, Iss 1, Pp 1-10 (2019) 
787 0 |n http://link.springer.com/article/10.1186/s13048-019-0494-4 
787 0 |n https://doaj.org/toc/1757-2215 
856 4 1 |u https://doaj.org/article/b18d2e2729b64eb0be39d117e69b48df  |z Connect to this object online.